Comparison of Clinical and Pathological Staging in Head and Neck Squamous Cell Carcinoma Results From Intergroup Study ECOG 4393/RTOG 9614
Comparison of Clinical and Pathological Staging in Head and Neck Squamous Cell Carcinoma Results From Intergroup Study ECOG 4393/RTOG 9614
复制标题
DOI:
10.1001/archoto.2009.123
复制
发表时间:
2009-09-01
影响因子:
--
通讯作者:
Manola, Judith
中科院分区:
文献类型:
--
作者:
Koch, Wayne M.;Ridge, John A.;Manola, Judith
Objectives: To compare the results of clinical and pathological staging for a large cohort of patients with head and neck squamous cell carcinoma (HNSCC) and to examine patterns and ramifications of the disparity between staging methods.Design: Prospective inception cohort (median follow-up, 7 years).Setting: Multi-institutional cooperative group study (Eastern Cooperative Oncology Group 4393/Radiation Therapy Oncology Group 9614) involving 17 academic medical centers.Patients: A total of 560 patients with new-onset or recurrent HNSCC enrolled during a 7-year period.Interventions: Surgical resection with curative intent with or without adjuvant or previous radiotherapy or chemotherapy.Main Outcome Measures: Clinical staging and pathological staging and the component TN tumor categorieswere compared with overall and disease-specific Survival. Association of survival With staging was derived by means Of the proportional hazards model.Results: Of the 501 cases in which both clinical and pathological staging was available, a disparity was found between at least 1 component tumor category assigned by the 2 methods in almost 50% of cases. Both methods showed a strong association of stage with overall survival for the cohort at large. However, pathological nodal category was a superior predictor (P